Abbott Laboratories
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IE
US
US
US
US
US
IN
US
US
US
US
US
US
US
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Track Abbott Laboratories in real time with a live news feed covering Abbott Laboratories stock news, official press releases, company announcements, and an archive of historical Abbott Laboratories news. ...more
Loading news...
Loading more...
7:21 AM | Thursday | Oct 1, 2026
Sign in to download news snippet
A secretary at an Illinois pharmaceutical company made a single, unremarkable stock purchase in 1935 and then did almost nothing for the next 75 years. What her college discovered when she died would quietly rewrite everything anyone thought they knew about her.
Read full articleNo data available for this time period.
Change the time range to see results.
A secretary at an Illinois pharmaceutical company made a single, unremarkable stock purchase in 1935 and then did almost nothing for the next 75 years. What her college discovered when she died would quietly rewrite everything anyone thought they knew about her.
Read full article
ABBOTT PARK, Ill., Sept. 30, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its third-quarter 2026 financial results on Wednesday, Oct. 21, before the market opens.
Read full article
Only Abbott offers a complete screening solution combining end-to-end support with both stool- and blood-based colorectal cancer screening options, giving healthcare providers more ways to help eligible patients get screened1-3 SimpleScreen CRC expands screening options for adults age 45 and older, providing another way to help reach people who otherwise may remain unscreened SimpleScreen CRC is covered by Medicare, with no out-of-pocket costs for eligible patients with Medicare Part B ABBOTT PARK, Ill., Sept. 30, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) today announced the U.S. commercial launch of SimpleScreen™ CRC, an FDA-approved blood-based colorectal cancer (CRC) screening test for adults age 45 and older who are at average risk for the disease.
Pacemakers and glucose monitors keep selling whether the economy booms or collapses, and three medical device giants have spent decades turning that predictable demand into paychecks that grow every single year.
Read full article
Dividend Kings are underperforming SPY in September, with a -4.22% average return versus SPY's marginal gain. Despite aggregate weakness, 29 Dividend Kings appear both undervalued and offer a long-term expected return of at least 10%. Recent dividend increases and higher projected earnings growth have modestly improved the Kings' average dividend growth rate to 4.49%.
Investors with an interest in Medical - Products stocks have likely encountered both Envista (NVST) and Abbott (ABT). But which of these two companies is the best option for those looking for undervalued stocks?
Read full articleEnvestnet Asset Management Inc. trimmed its position in shares of Abbott Laboratories (NYSE: ABT) by 23.7% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,956,395 shares of the healthcare product maker's stock after selling 1,228,773 shares during
Read full article
Engineers Gate Manager LP reduced its position in Abbott Laboratories (NYSE: ABT) by 97.1% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,990 shares of the healthcare product maker's stock after selling 165,381 shares during the period. Engineers Gate Manager
Read full article
Representative Rick W. Allen (Republican-Georgia) recently bought shares of Taiwan Semiconductor Manufacturing Company Ltd. (NYSE: TSM). In a filing disclosed on September 22nd, the Representative disclosed that they had bought between $1,001 and $15,000 in Taiwan Semiconductor Manufacturing stock on August 12th. The trade occurred in the Representative's "R.
W. ALLEN and ASSOCIATES, INC. > RWA&A -
Representative Rick W. Allen (Republican-Georgia) recently bought shares of Broadcom Inc. (NASDAQ: AVGO). In a filing disclosed on September 22nd, the Representative disclosed that they had bought between $1,001 and $15,000 in Broadcom stock on August 12th. The trade occurred in the Representative's "R.
W. ALLEN and ASSOCIATES, INC. > RWA&A - SECURITIES" account. Representative Rick W.
No data available for this time period.
Change the time range to see results.